Boutique specialty distributor with a theatrical-first commitment and a focused appetite for European arthouse, Italian cinema, and character-driven indie drama.
Each signal is one documented data point captured by our continuous pipeline: a trade-press mention, festival market activity, executive statement, or acquisition activity update. Higher signal volume means Cohen Media Group is generating more public market activity right now.
A theatrical-only specialty distributor that filmmakers actively seek out when they want to avoid streaming-direct deals. The Trifole 150-screen rollout is the recent signal.
Cohen Media Group operates at the smaller-volume end of the U.S. specialty distribution market, but with one of the most distinctive value propositions: an explicit theatrical-first commitment that filmmakers actively seek out. The company's recent rollout of Trifole on roughly 150 screens, including New York's Quad Cinema (which Cohen owns) and theaters in Los Angeles and major U.S. markets, exemplifies the model. Filmmakers behind Trifole publicly cited Cohen's theatrical commitment as the reason they chose the partnership over streaming-direct alternatives.
The slate skews European, with a particular focus on Italian cinema. Trifole follows the company's release of Matteo Garrone's Io Capitano, which earned 2024 Oscar and Golden Globe nominations. Other recent acquisitions include Franz (October 2025) and The Great Arch (October 2025). The territorial scope is domestic, which gives Cohen flexibility to acquire titles where the international rights are pre-allocated to other distributors. Volume is intentionally low — the company averages a small number of theatrical releases per year, each given a focused theatrical rollout.
Access pattern is rep-driven, with most acquisitions surfacing through sales agents who package European arthouse cinema for U.S. theatrical release. Festival presence at Cannes Marché du Film is documented (the Trifole deal was negotiated in May 2026). Direct cold query has effectively zero conversion. The most reliable pathway is a sales-agent representative who specializes in European or international cinema with a strong theatrical case for a U.S. arthouse release.
A theatrical-only specialty distributor that filmmakers actively seek out when they want to avoid streaming-direct deals. The Trifole 150-screen rollout is the recent signal.
Aligns with market trend of boutique distributors acquiring festival-winning international films for prestige theatrical releases; reflects continued demand for music biopics and character studies with strong ensemble casts.
This page is a public snapshot of Cohen Media Group, kept fresh from trade-press signals. ScriptMatch is the live market-data engine behind it. Upload your script, and we use the same continuously-indexed buyer activity to tell you which production companies and distributors are actively acquiring projects like yours right now, why each one fits, and exactly how to reach them.
No. Cohen Media Group operates as a rep-only buyer at intake, with most acquisitions coming through sales-agent relationships that package international cinema for U.S. theatrical release. The company does not maintain an open submission portal.
Acquisition prices skew lower in the specialty market because the focus is U.S. domestic theatrical rights on completed international films rather than higher-priced packages with star talent. Most deals land in the lower seven-figure range. The company is comfortable with smaller acquisition prices in exchange for a theatrical-first commitment that many filmmakers prioritize.
Cannes Marché du Film is the dominant sourcing channel — the Trifole acquisition was negotiated there in May 2026. Cohen also works major European festivals (Venice, Berlin, San Sebastian) where Italian and other European cinema premieres.
The realistic pathway is sales-agent representation specializing in European or international arthouse cinema with strong U.S. theatrical positioning. The company is particularly receptive to Italian cinema and to filmmakers explicitly seeking a theatrical-first U.S. release. Direct cold query has zero conversion.
International arthouse drama, Italian cinema specifically (Trifole, Io Capitano), character-driven European indie work, and selective music biopics. Recent acquisitions span the smaller-scale prestige theatrical lane rather than wide commercial genre material.
Yes, at curated low volume. Cohen has documented 13 signals over the past 12 months, with the most recent deal (Trifole) negotiated at Cannes Marché du Film in May 2026. The company is one of the few remaining U.S. distributors with a clear theatrical-first identity, which is increasingly rare in the specialty market and makes Cohen a meaningful partner for filmmakers prioritizing that model.
Profile compiled from publicly-available sources: trade press (Deadline, Variety, IndieWire, The Hollywood Reporter, Screen Daily), festival market reports (Cannes Marche, AFM, EFM, TIFF Industry), executive public statements, and acquisition announcements. Activity counters reflect signal volume from continuous pipeline indexing.
See an inaccuracy? Suggest a correction. Profiles update continuously as new public information becomes available.